1. Pink Sheet
  2. >>Biosimilars & Generics
  3. >>Generics

USP Map Charts Way To Medicine Supply Resiliency

 
• By Bowman Cox

Supply chain project shows which drug products are at greatest risk in different scenarios – and which responses would do the most to prevent shortages. Officials from the pharmacopoeial group share how it works and what it can do to help bake in resilience against pandemics, natural disasters, trade wars and shooting wars.

global supply chain map
usp tool plumbs data for hidden supply chain vulnerabilities • Source: Alamy

The Medicine Supply Map project that USP has been developing during the COVID-19 pandemic is beginning to yield insights as the pharmacopoeia lays the groundwork for it potentially to become a part of how government and industry stakeholders prevent drug shortages.

Key Insights

By combining and analyzing data, USP has identified key pharmaceutical supply chain challenges and opportunities:

  • Five main types of vulnerabilities can be quantified, showing which to attack to strengthen each product’s supply.

  • Four or five competitors are best for resilience.

  • India hosts the most large API plants, not China

The map is bringing the global pharmaceutical supply chain’s vulnerabilities into focus, with some early findings on

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Generics

More from Biosimilars & Generics